38 news items
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
BMY
10 May 24
overall survival (OS) across the study arms, PFS by RECIST 1.1 per BICR across the study arms, as well as objective response rate (ORR), time
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
BMY
29 Apr 24
, it will deploy DECODE to monitor immune responses to the tolerizing vaccines in patients during clinical development to provide key insights
Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights
BMY
26 Apr 24
', or 'Lower' their stance, it signifies their response to recent developments related to Bristol-Myers Squibb. This offers insight into analysts' perspectives
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
BMY
26 Apr 24
of care for decades but the durability of response to chemotherapy alone is poor and once a patient progresses, treatment options become increasingly
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
BMY
25 Apr 24
response
gylxze7
AGEN
BMY
12 Apr 24
response rate (ORR) was observed after a median follow up of 13.6 months at the data cutoff of March 1, 2024.
The median duration
19zohrrpimn7ksy68hcpduq5txkq3vn8g7315l6l28tucgm8irvmvudj6
BMY
JNJ
MRK
10 Apr 24
continues to build its heart business.
Johnson & Johnson is focusing on enhancing its cardiovascular health business in response to its
cb0dfj0jon29z41p6f3l551mqupphk
BMY
8 Apr 24
.
With a median follow-up of 11.9 months in 94 patients, Krazati plus cetuximab demonstrated an objective response rate, the primary endpoint, of 34%, median
gs0b7umq0e5czlhixa25nnvy4k1
BMY
TSVT
5 Apr 24
showed a significant improvement in overall response rates (p<0.0001) with the majority (71%) of patients treated
qai9wrv192nuul8ycp88hnppb84qm53q0t4yzru3isbnutpviay0nk95gqdz
BMY
IRON
VERV
4 Apr 24
with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy. It is also indicated for the treatment
87l6gq
BMY
LAB
3 Apr 24
on the development of these new tools that will accelerate insights into disease response," says Michael Egholm, President and Chief Executive Officer
pe4eu0vtc5coj20x drdyaw6vlfnt1x9g6l2u3cm46xaonipp5
BMY
2 Apr 24
.
"In the treatment of lower-risk MDS, few patients experience a lasting response to erythroid stimulating agents, leaving a critical need for more
eq3wu0 oy
BMY
2 Apr 24
.
Established Principles for Responsible Artificial Intelligence: BMS defined and published ethical standards and practical requirements
izj5bhc6xi 5qmuzvl8zfbg9tjxvrf96advdvyl9v4hjfritzu5i9tp
BMY
ZLAB
1 Apr 24
mutation.
The study met the primary endpoint of progression-free survival (PFS) and the key secondary endpoint of overall response rate (ORR
suo421kvxfyj431nsrv
BMY
CATX
LNTH
28 Mar 24
and Drug Administration ("FDA") based on preclinical data for the indication of SSTR2-positive NETs regardless of prior treatment response
xmoit1mqizinxt2zooybowjetig7e93
BMY
25 Mar 24
, monitor LVEF closely until stable doses and clinical response have been achieved